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Abstract 
Epidemiological evidence consistently shows that males have a higher susceptibility to non-sex-
specific cancers. For some cancers, the sex difference is clearly due to behavioral differences. 
Differences in morphology such as greater weight and height, and genetic and physiology also 
play a role, but exact details are missing. The differences between males and females at 
transcriptomics, epigenomics, proteomics, and metabolomics levels are emerging and should 
shed light on the mechanisms of the sex difference in cancer susceptibility. This chapter 
provides an overview of the epidemiologic background, differences between males and females 
relevant to cancer development, with a focus on gene expression and epigenetics, and specific 
examples of molecular mechanisms in liver and kidney cancers. Despite strong calls by 
agencies and journals, sex-specific analysis of research data is still only rarely done. Only more 
experimental data will help to gain the information about on the exact nature of this difference, 
which can then be used for better diagnosis and treatment.   
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